Clinical Trial Detail

NCT ID NCT03187288
Title A Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

CFI-400945

Age Groups: senior adult

No variant requirements are available.